tiprankstipranks
VAXX Earnings this Week: How Will it Perform?
PremiumPre-EarningsVAXX Earnings this Week: How Will it Perform?
1M ago
Vaxxinity Inc Motivates Team with Option Repricing Initiative
PremiumCompany Announcements
Vaxxinity Inc Motivates Team with Option Repricing Initiative
1M ago
Vaxxinity announces ‘positive’ target engagement data from Phase 1 trial
PremiumThe Fly
Vaxxinity announces ‘positive’ target engagement data from Phase 1 trial
2M ago
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
PremiumPress ReleasesVaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
2M ago
Vaxxinity announces research collaboration with CTRND
PremiumThe Fly
Vaxxinity announces research collaboration with CTRND
3M ago
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
PremiumPress Releases
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
3M ago
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update
PremiumPress ReleasesVaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6M ago
Vaxxinity reports Q3 EPS (10c), consensus (12c)
PremiumThe Fly
Vaxxinity reports Q3 EPS (10c), consensus (12c)
6M ago
Baird starts Vaxxinity with Outperform, $7 price target
PremiumThe Fly
Baird starts Vaxxinity with Outperform, $7 price target
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100